Table 2 Therapeutic profile and other processes in pregnant women with HIV identified in the pilot study
From: Prevention of mother-to-child HIV transmission program in Iran
Variable | Frequency | % | |
|---|---|---|---|
CD4 count testing before treatment | Yes | 66 | 86.8 |
No | 10 | 13.2 | |
CD4 count level before treatment | < 350 | 18 | 23.7 |
> 350 | 48 | 63.2 | |
Viral load testing before treatment | Yes | 22 | 28.9 |
No | 54 | 71.1 | |
Viral load level before treatment | < 200 copies/ml | 5 | 22.7 |
> 200 copies/ml | 17 | 77.3 | |
ART adherence during the pregnancy | Yes | 66 | 86.8 |
No | 10 | 13.2 | |
CD4 count testing after treatment | Yes | 57 | 75 |
No | 19 | 25 | |
CD4 count level after treatment | < 350 | 10 | 17.5 |
> 350 | 47 | 82.5 | |
Viral load testing after treatment | Yes | 33 | 43.4 |
No | 43 | 56.6 | |
Viral load level after treatment | < 200 copies/ml | 28 | 84.8 |
> 200 copies/ml | 5 | 15.2 | |
Lifelong ART adherence after delivery | Lifelong ART adherence | 67 | 89.3 |
Lack of full adherence to ART | 2 | 2.7 | |
Death | 0 | 0 | |
Pregnant at the moment of the study | 7 | 9.2 | |
Consultancy with husband | Yes | 57 | 75.0 |
Rejected counselling | 5 | 6.6 | |
Under follow up | 14 | 18.4 | |
HIV testing for husband | No | 19a | 25 |
HIV Negative | 19 | 25 | |
HIV positive | 38 | 50 | |
HIV situation in husband | New case | 15 | 39.5 |
Previously registered | 23 | 60.5 |